MOR - MorphoSys AG

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in EUR. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue76,442.50566,790.8449,743.515106,222.897
Cost of Revenue1,796.629---
Gross Profit74,645.87666,790.8449,743.515106,222.897
Operating Expenses
Research Development87,208.017103,450.09783,821.78874,932.052
Selling General and Administrative28,310.24120,533.61615,876.17915,072.046
Non Recurring----
Others----
Total Operating Expenses117,314.887123,983.71399,697.96790,004.098
Operating Income or Loss-40,872.382-57,192.873-49,954.45216,218.799
Income from Continuing Operations
Total Other Income/Expenses Net-19,604.413-11,597.231-9,909.6994,406.769
Earnings Before Interest and Taxes-40,872.382-57,192.873-49,954.45216,218.799
Interest Expense-179-374-20-20
Income Before Tax-60,476.795-68,790.104-59,864.15120,625.568
Income Tax Expense-4,304.6741,036.365518.6255,724.8
Minority Interest----
Net Income From Continuing Ops-56,172.121-69,826.469-60,382.77614,900.768
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-56,172.121-69,826.469-60,382.77614,900.768
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-56,172.121-69,826.469-60,382.77614,900.768